Voruciclib is a small-molecule inhibitor of cyclin-dependent kinases. Voruciclib inhibits the proliferation of cancer cells by inducing apoptosis by inhibiting the expression and activity of the MCL-1 protein, which regulates cell death pathways. Reagent grade, for research purpose.
Usually ships within 24 hours.